NCT02354703 Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder Status COMPLETED Phase PHASE2
NCT02322047 Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders Status COMPLETED Phase PHASE2
NCT02252536 HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder Status COMPLETED Phase PHASE2
NCT02210195 Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence Status COMPLETED Phase PHASE2
NCT02188043 Project Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals Status COMPLETED Phase NA
NCT02185131 Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. Status COMPLETED Phase PHASE2
NCT02161718 A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder Status COMPLETED Phase PHASE2
NCT02108054 Behavioral and Functional Task Development, Implementation, and Testing Status RECRUITING Phase NA
NCT02094196 The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders Status COMPLETED Phase N/A
NCT02060162 Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa Status COMPLETED Phase N/A